Junlong Wu
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
Papers in
-
- Prostate Cancer Treatment and Research 14
- Renal cell carcinoma treatment 12
- Prostate Cancer Diagnosis and Treatment 5
- Surgery 14
- Bladder and Urothelial Cancer Treatments 6
- Cervical and Thoracic Myelopathy 2
- Testicular diseases and treatments 2
- Co-authors
- Yao Zhu (31 shared papers)Wei Yu (21 shared papers)Dingwei Ye (20 shared papers)Jian Gang Pan (15 shared papers)Dingwei Ye (8 shared papers)Stephen J. Freedland (4 shared papers)Bo Dai (13 shared papers)Weijie Gu (12 shared papers)
- Journals
- Frontiers in Oncology (6 papers)Scientific Reports (3 papers)Cell Reports Medicine (3 papers)Journal of Cancer (3 papers)Asian Journal of Andrology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Junlong Wu
61 papers receiving 1.2k citations
Junlong Wu's Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 428
- Oncology 207
- Cancer Research 103
- Surgery 165
- Drug Discovery 1
Countries citing papers authored by Junlong Wu
This map shows the geographic impact of Junlong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junlong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junlong Wu more than expected).
Fields of papers citing papers by Junlong Wu
This network shows the impact of papers produced by Junlong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junlong Wu. The network helps show where Junlong Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Junlong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epidemiology and genomics of prostate cancer in Asian men Hit paper breakdown → | 2021 | 196 |
| 2 | 2019 | 111 | |
| 3 | 2009 | 52 | |
| 4 | 2019 | 50 | |
| 5 | 2019 | 41 | |
| 6 | 2017 | 40 | |
| 7 | Minimally Invasive Full-Endoscopic Posterior Cervical Foraminotomy Assisted by O-Arm-Based Navigation. | 2018 | 40 |
| 8 | 2018 | 40 | |
| 9 | 2020 | 30 | |
| 10 | 2018 | 26 | |
| 11 | 2020 | 26 | |
| 12 | 2019 | 24 | |
| 13 | 2022 | 23 | |
| 14 | 2017 | 22 | |
| 15 | 2018 | 22 | |
| 16 | 2018 | 22 | |
| 17 | 2019 | 22 | |
| 18 | 2020 | 22 | |
| 19 | 2021 | 21 | |
| 20 | 2024 | 21 |
About Junlong Wu
Junlong Wu is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Cancer Research, Oncology and Genetics, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (14 papers), Renal cell carcinoma treatment (12 papers), Bladder and Urothelial Cancer Treatments (6 papers), BRCA gene mutations in cancer (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cervical and Thoracic Myelopathy (2 papers) and Testicular diseases and treatments (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (428 citations), Oncology (207 citations), Cancer Research (103 citations), Surgery (165 citations) and Drug Discovery (1 citation). Junlong Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yao Zhu, Wei Yu, Dingwei Ye, Jian Gang Pan, Dingwei Ye, Stephen J. Freedland, Bo Dai, Weijie Gu, Miao Mo and Ying Zheng. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Cell Reports Medicine, Journal of Cancer and Asian Journal of Andrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.